Subscribe
Subscription banner for an ophthalmic newsletter

Breaking News

FDA Approves Revakinagene Taroretcel-Lwey (ENCELTO) for Macular Telangiectasia Type 2
FDA Approves Revakinagene Taroretcel-Lwey (ENCELTO) for Macular Telangiectasia Type 2 Mar 07, 2025 The US Food and Drug Administration (FDA) has granted approval for revakinagene taroretcel-lwey (ENCELTO), developed by Neurotech Pharmaceuticals, marking the first-ever FDA-approved treatment for Macular Telangiectasia type 2 (MacTel).
FDA Approves Purified Cortrophin Gel Prefilled Syringe from ANI Pharmaceuticals
FDA Approves Purified Cortrophin Gel Prefilled Syringe from ANI Pharmaceuticals Mar 05, 2025 The US Food and Drug Administration (FDA) has approved ANI Pharmaceuticals’ Purified Cortrophin Gel (repository corticotropin injection USP) in a prefilled syringe format.
China Approves Zeiss Visumax 800 with SMILE Pro Software
China Approves Zeiss Visumax 800 with SMILE Pro Software Feb 27, 2025 Carl Zeiss Meditec AG, headquartered in Jena, Germany, has announced that its Visumax 800 femtosecond laser with SMILE pro software has received approval from the National Medical Products Administration (NMPA) in China.

 

a banner for OBN's Spotlight TV series. Showing 5 people in ophthalmic sector

Industry News

Luxa Biotechnology Presents Promising Phase 1/2a Trial Data for RPESC-RPE-4W in Dry AMD
Luxa Biotechnology Presents Promising Phase 1/2a Trial Data for RPESC-RPE-4W in Dry AMD Mar 10, 2025 Luxa Biotechnology has presented clinical data from its Phase 1/2a trial evaluating RPESC-RPE-4W at the 77th Annual Wills Eye Conference in Philadelphia on March 6, 2025
Lumata Health Secures $23 Million Series B Funding to Expand Vision-Saving Technology
Lumata Health Secures $23 Million Series B Funding to Expand Vision-Saving Technology Mar 10, 2025 Lumata Health has raised $23 million in Series B funding, bringing its total funding to $36 million since inception.
Optos Unveils MonacoPro Ultra-Widefield and OCT Retinal Imaging Technology
Optos Unveils MonacoPro Ultra-Widefield and OCT Retinal Imaging Technology Mar 06, 2025 Optos has announced the launch of MonacoPro, the next-generation ultra-widefield (UWF) SLO and spectral domain OCT retinal imaging solution. Building

Ophthalmic Research News

The Pupil as a Window to the Sleeping Brain: New Research Reveals Unexpected Brain Activity During Sleep
The Pupil as a Window to the Sleeping Brain: New Research Reveals Unexpected Brain Activity During Sleep Mar 10, 2025 For the first time, researchers have been able to observe how pupils react during sleep over an extended period, revealing surprising fluctuations in brain activity.
Diabetic Eye Disease on the Rise, but Most Severe Forms Declining Since 2014
Diabetic Eye Disease on the Rise, but Most Severe Forms Declining Since 2014 Mar 07, 2025 The prevalence of diabetes-related eye diseases has nearly doubled since 2014, yet the most severe forms of the disease have shown a steady decline, according to a recent study led by the Perelman School of Medicine at the University of Pennsylvania
Association Between Triglyceride-Glucose Index and Central Retinal Artery Occlusion
Association Between Triglyceride-Glucose Index and Central Retinal Artery Occlusion Mar 06, 2025 A new study from Turkey highlights a significant correlation between the triglyceride-glucose (TyG) index and central retinal artery occlusion (CRAO).

Ophthalmic Blog

AI in Ophthalmology: Top Artificial Intelligence Tools Transforming Eye Health
AI in Ophthalmology: Top Artificial Intelligence Tools Transforming Eye Health Mar 07, 2025 The AI in ophthalmology sector is evolving rapidly, introducing Artificial Intelligence tools in ophthalmology that enhance diagnostic accuracy, efficiency, and accessibility.
2024 Recap: Top 8 Groundbreaking Innovations in Eye Disease Therapies and Technologies
2024 Recap: Top 8 Groundbreaking Innovations in Eye Disease Therapies and Technologies Dec 23, 2024 The year 2024 has been a remarkable period for advancements in ophthalmology, with groundbreaking innovations reshaping the landscape of eye disease treatment and diagnosis.
2024 Recap: Top 8 FDA Approvals in Ophthalmology
2024 Recap: Top 8 FDA Approvals in Ophthalmology Dec 16, 2024 The year 2024 has been a pivotal one for ophthalmology, with several novel FDA approvals introducing innovative treatments and technologies to the field
Ophthalmology Breaking News Subscribe